We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$507M
AUM Growth
-$160M
(-24%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-21.48%
Top 10 Holdings %
Top 10 Hldgs %
40.1%
Holding
696
New
71
Increased
159
Reduced
213
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$11.9M |
| 2 |
Deutsche Bank
DB
|
+$11.9M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$10.4M |
| 4 |
RSX
VanEck Russia ETF
RSX
|
+$9.67M |
| 5 |
AB InBev
BUD
|
+$9.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Thailand ETF
THD
|
+$12.4M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$12.1M |
| 3 |
iShares MSCI Peru and Global Exposure ETF
EPU
|
+$9.29M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$9.27M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.36% |
| 2 | Technology | 8.28% |
| 3 | Consumer Staples | 6.89% |
| 4 | Consumer Discretionary | 6.15% |
| 5 | Healthcare | 5.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Deutsche Bank
DB
$66.6B
| $33.5M | 6.61% |
2,063,487
+843,180
| +69% | +$11.9M |
|
|
2
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $31.1M | 6.14% |
888,524
+329,934
| +59% | +$11.9M |
|
|
3
PUT
Deutsche Bank
DB
$66.6B
| $26.8M | 5.29% |
90,065
-46,689
| -34% | -$658K |
|
|
4
iShares China Large-Cap ETF
FXI
$4.32B
| $24.1M | 4.75% |
693,424
+282,421
| +69% | +$10.4M |
|
5
United States Oil Fund
USO
$2.15B
| $20.6M | 4.07% |
219,745
-59,493
| -21% | -$5.25M |
|
|
6
CALL
Deutsche Bank
DB
$66.6B
| $20.5M | 4.05% |
74,358
+757
| +1% | +$10.7K |
|
|
RSX
7
DELISTED
VanEck Russia ETF
RSX
| $15.9M | 3.14% |
749,846
+498,662
| +199% | +$9.67M |
|
8
UBS Group
UBS
$170B
| $12.7M | 2.51% |
813,750
-320,204
| -28% | -$4.82M |
|
|
9
AB InBev
BUD
$164B
| $11.3M | 2.23% |
107,101
+81,529
| +319% | +$9.14M |
|
|
CTLT
10
DELISTED
CATALENT, INC.
CTLT
| $6.65M | 1.31% |
246,886
+75,762
| +44% | +$1.88M |
|
11
Colgate-Palmolive
CL
$74.8B
| $5.8M | 1.15% |
88,708
-23,752
| -21% | -$1.63M |
|
12
Illumina
ILMN
$29.5B
| $5.57M | 1.1% |
44,745
+44,744
| +4,474,400% | +$6.03M |
|
|
13
CALL
UBS Group
UBS
$170B
| $5.49M | 1.08% |
34,103
+3,500
| +11% | +$52.7K |
|
14
Alphabet (Google) Class A
GOOGL
$4.12T
| $4.95M | 0.98% |
124,980
+104,180
| +501% | +$4.17M |
|
15
Blackstone
BX
$104B
| $4.95M | 0.98% |
183,051
+37,986
| +26% | +$986K |
|
|
16
PUT
United States Oil Fund
USO
$2.15B
| $4.9M | 0.97% |
2,468
-1,804
| -42% | -$159K |
|
17
Meta Platforms (Facebook)
META
$1.49T
| $4.34M | 0.86% |
37,687
-29,572
| -44% | -$3.63M |
|
|
18
PUT
UBS Group
UBS
$170B
| $4.32M | 0.85% |
44,003
-22,037
| -33% | -$332K |
|
19
Constellation Brands
STZ
$22.5B
| $4.31M | 0.85% |
28,147
+27,285
| +3,165% | +$4.33M |
|
20
Broadcom
AVGO
$1.76T
| $4.26M | 0.84% |
241,050
-239,820
| -50% | -$4.15M |
|
21
AstraZeneca
AZN
$269B
| $4.24M | 0.84% |
77,573
-45,065
| -37% | -$2.56M |
|
22
Devon Energy
DVN
$51.3B
| $4.19M | 0.83% |
91,811
+8,741
| +11% | +$386K |
|
23
CALL
Stellantis
STLA
$17.4B
| $4.19M | 0.83% |
4,157
-4,524
| -52% | -$33.8K |
|
|
BCR
24
DELISTED
CR Bard Inc.
BCR
| $4.18M | 0.83% |
18,629
-18,016
| -49% | -$3.91M |
|
25
Applied Materials
AMAT
$347B
| $4.18M | 0.82% |
129,431
-147,203
| -53% | -$4.48M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2016 Portfolio in Review
As of Q4 2016, Exane Derivatives held 696 positions worth $507M, down 24% from $666M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Exane Derivatives withdrew a net $109M in Q4 2016, closing 50 positions and reducing 213 holdings. Its most notable exit was Vale, an estimated $8.59M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 6.6% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Exane Derivatives opened a new position in Ingredion worth $4.09M.
- Exane Derivatives's largest Q4 2016 buy was Ingredion: 32,719 shares worth $4.09M.
- Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q4 2016, an estimated $11.9M increase.
- Exane Derivatives's biggest Q4 2016 reduction was iShares MSCI Thailand ETF, cutting an estimated $12.4M.
- Exane Derivatives fully exited Vale in Q4 2016, selling an estimated $8.59M.
- Exane Derivatives's ten largest holdings make up 40% of its $507M portfolio in Q4 2016.
- Exane Derivatives opened 71 new positions and closed 50 in Q4 2016.
- Exane Derivatives's portfolio value fell 24% quarter-over-quarter to $507M.
Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.